DVA - DaVita Inc.
NEXT EARNINGS:
May 11, 2026
EPS Est: $2.41
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$168.67
DETAILS
HIGH:
$190.00
LOW:
$158.00
MEDIAN:
$158.00
CONSENSUS:
$168.67
UPSIDE:
11.77%
Market Cap:
10.09B
Volume:
590,738
Avg Volume:
1,100,108
52 Week Range:
101-157.12
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
1.01
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
76,000
IPO Date:
1995-10-31
EPS (TTM):
9.72
P/E Ratio:
13.10
Revenue (TTM):
13.64B
Total Assets:
17.48B
Total Debt:
15.05B
Cash & Equiv:
757.75M
Rev Growth (5Y):
3.4%
EPS Growth (5Y):
8.2%
FCF Growth (5Y):
0.1%
ROCE:
13.4%
Debt/Equity:
99.63
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-02 | $3.40 | $3.24 | +4.9% | $3.6B | $3.3B | +8.4% |
| 2025-10-29 | $2.51 | $3.17 | -20.8% | $3.4B | $3.4B | -0.2% |
| 2025-08-05 | $2.95 | $2.70 | +9.3% | $3.4B | $3.4B | -1.8% |
| 2025-05-12 | $2.00 | $1.95 | +2.6% | $3.2B | $3.2B | +0.5% |
| 2025-02-13 | $2.24 | $2.14 | +4.7% | $3.3B | $3.3B | +0.9% |
| 2024-10-29 | $2.59 | $2.72 | -4.8% | $3.3B | $3.3B | 0.0% |
| 2024-08-06 | $2.50 | $2.54 | -1.6% | $3.2B | $3.2B | +1.1% |
| 2024-05-02 | $2.26 | $1.95 | +15.9% | $3.1B | $3.0B | +1.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.64B | 12.82B | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 14.75B | 13.78B | 12.80B |
| Net Income | 746.80M | 936.34M | 691.53M | 560.40M | 978.45M | 773.64M | 810.98M | 159.39M | 663.62M | 879.87M | 269.73M | 723.11M |
| EPS | 9.72 | 11.02 | 7.62 | 6.03 | 9.30 | 6.54 | 5.29 | 4.63 | 3.52 | 4.36 | 1.27 | 3.41 |
| Total Assets | 17.48B | 17.29B | 16.89B | 16.93B | 17.12B | 16.99B | 17.31B | 19.11B | 18.95B | 18.74B | 18.48B | 17.94B |
| Total Debt | 15.05B | 12.07B | 11.12B | 11.82B | 11.98B | 11.19B | 11.18B | 10.10B | 9.34B | 9.11B | 9.13B | 8.50B |
| Cash & Equivalents | 757.75M | 794.93M | 380.06M | 244.09M | 461.90M | 324.96M | 1.10B | 323.04M | 508.23M | 674.78M | 1.50B | 965.24M |
| Operating Cash Flow | 1.89B | 2.02B | 2.06B | 1.56B | 1.93B | 1.98B | 2.07B | 1.77B | 1.91B | 1.96B | 1.56B | 1.46B |
| Free Cash Flow | 1.31B | 1.47B | 1.49B | 961.14M | 1.29B | 1.30B | 1.31B | 784.50M | 1.00B | 1.13B | 849.20M | 817.06M |
| FCF per Share | 15.22 | 17.26 | 16.42 | 10.34 | 12.25 | 10.89 | 8.52 | 4.59 | 5.31 | 5.63 | 4.01 | 3.85 |
| Book Value | (651.08M) | 121.12M | 1.06B | 712.33M | 755.51M | 1.38B | 2.13B | 3.70B | 4.69B | 4.65B | 4.87B | 5.17B |
| Cash & ST Investments | 782.05M | 846.00M | 391.67M | 321.78M | 484.21M | 345.06M | 1.11B | 325.97M | 541.06M | 981.76M | 1.91B | 1.30B |
| ROC Equity | N/A | 7.73 | 0.65 | 0.79 | 1.30 | 0.56 | 0.38 | 0.04 | 0.14 | 0.19 | 0.06 | 0.14 |